22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
22nd Century Group is a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology.